{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:25:17Z","timestamp":1772166317619,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572416"],"award-info":[{"award-number":["81572416"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802430"],"award-info":[{"award-number":["81802430"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Science & Technology Development Fund of Tianjin Education Commission for Higher Education","award":["2021KJ196"],"award-info":[{"award-number":["2021KJ196"]}]},{"name":"Tianjin Health Commission, Tianjin Administration of Traditional Chinese Medicine, Integrated Chinese and Western medicine research program","award":["2021074"],"award-info":[{"award-number":["2021074"]}]},{"name":"National Key Technologies R&D Program of China","award":["2016YFC1303200"],"award-info":[{"award-number":["2016YFC1303200"]}]},{"name":"Tianjin Science and Technology Commission Major Science and Technology Special Project for New Drug Development","award":["18ZXXYSY00130"],"award-info":[{"award-number":["18ZXXYSY00130"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Colon cancer (CC) ranks the second highest mortality rate among malignant tumors worldwide, and the current mainstream treatment regimens are not very effective. The unique efficacy of Chinese herb medicine (CHM) for cancer has recently attracted increasing attention.\n                      <jats:italic>Cinnamomi Ramulus<\/jats:italic>\n                      (CR), as a classic CHM, has been widely used in the treatment of a variety of diseases for hundreds of years in China, but its specific pharmacological mechanism against CC needs to be fully evaluated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>TCMSP and China National Knowledge Infrastructure database were utilized to predict the candidate ingredients of CR, and TCMSP and SwissTargetPrediction database were also employed to predict the drug targets of the candidate ingredients from CR. We subsequently evaluated the therapeutic effect of CR by orally administrating it on CC-bearing mice. Next, we further identified the potential CC-related targets by using Gene Expression Omnibus (GEO) database. Based on these obtained targets, the drug\/disease-target PPI networks were constructed using Bisogenet plugin of Cytoscape. The potential core therapeutic targets were then identified through topological analysis using CytoNCA plugin. GO and KEGG enrichment analyses were performed to predict the underlying mechanism of CR against CC. Furthermore, these in silico analysis results were validated by a series of cellular functional and molecular biological assays. UPLC\u2013MS\/MS method and molecular docking analysis were employed to identify the potential key components from CR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In this study, we firstly found that CR has potential therapeutic effect on cancer. Then, oral administration of CR could inhibit the growth of CC cells in C57BL\/6 mice, while inhibiting the viability and motility of CC cells in vitro. We obtained 111 putative core therapeutic targets of CR. Subsequent enrichment analysis on these targets showed that CR could induce apoptosis and cell cycle arrest in CC cells by blocking Akt\/ERK signaling pathways, which was further experimentally verified. We identified 5 key components from the crude extract of CR, among which taxifolin was found most likely to be the key active component against CC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results show that CR as well as its active component taxifolin holds great potential in treatment of CC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-022-00588-6","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T06:03:11Z","timestamp":1646805791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cinnamomi Ramulus inhibits the growth of colon cancer cells via Akt\/ERK signaling pathways"],"prefix":"10.1186","volume":"17","author":[{"given":"Boyu","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yafei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zilu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangjiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senbiao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7786-7874","authenticated-orcid":false,"given":"Liren","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,9]]},"reference":[{"key":"588_CR1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"588_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"588_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3322\/caac.21235","volume":"64","author":"CE DeSantis","year":"2014","unstructured":"DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS, Jemal A. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64:252\u201371.","journal-title":"CA Cancer J Clin"},{"key":"588_CR4","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1200\/JCO.2008.17.7147","volume":"26","author":"HK Sanoff","year":"2008","unstructured":"Sanoff HK, Sargent DJ, Campbell ME, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC, Goldberg RM. Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741. J Clin Oncol. 2008;26:5721\u20137.","journal-title":"J Clin Oncol"},{"key":"588_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3322\/caac.21395","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Reinier MGS, Barzi A, Jemal A. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177\u201393.","journal-title":"CA Cancer J Clin"},{"key":"588_CR6","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/S0140-6736(08)61354-9","volume":"372","author":"J Tang","year":"2008","unstructured":"Tang J, Liu B, Ma K. Traditional Chinese medicine. Lancet. 2008;372:1938\u201340.","journal-title":"Lancet"},{"key":"588_CR7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1177\/1534735417722224","volume":"17","author":"Y Kuo","year":"2018","unstructured":"Kuo Y, Liao H, Chiang J, Wu M, Chen B, Chang C, Yeh M, Chang T, Sun M, Yeh C, Yen H. Complementary Chinese herbal medicine therapy improves survival of patients with pancreatic cancer in Taiwan: a nationwide population-based cohort study. Integr Cancer Ther. 2018;17:411\u201322.","journal-title":"Integr Cancer Ther"},{"key":"588_CR8","first-page":"276","volume-title":"Chinese Pharmacopoeia","author":"Editorial Committee of Chinese Pharmacopoeia","year":"2015","unstructured":"Editorial Committee of Chinese Pharmacopoeia. Chinese Pharmacopoeia, vol. 1. Beijing: China Medical Science and Technology Press; 2015. p. 276."},{"key":"588_CR9","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.csbj.2020.05.004","volume":"18","author":"Y Dai","year":"2020","unstructured":"Dai Y, Qiang W, Yu X, Cai S, Lin K, Xie L, Lan X, Wang D. Guizhi Fuling decoction inhibiting the PI3K and MAPK pathways in breast cancer cells revealed by HTS2 technology and systems pharmacology. Comput Struct Biotechnol J. 2020;18:1121\u201336.","journal-title":"Comput Struct Biotechnol J"},{"key":"588_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.592903","volume":"11","author":"B Pan","year":"2021","unstructured":"Pan B, Wang Y, Wu C, Jia J, Huang C, Fang S, Liu L. A mechanism of action study on Danggui Sini Decoction to discover its therapeutic effect on gastric cancer. Front Pharmacol. 2021;11: 592903.","journal-title":"Front Pharmacol"},{"key":"588_CR11","volume":"2013","author":"G Zhang","year":"2013","unstructured":"Zhang G, Li Q, Chen Q, Su S. Network pharmacology: a new approach for Chinese herbal medicine research. Evid Based Complement Altern Med. 2013;2013: 621423.","journal-title":"Evid Based Complement Altern Med"},{"key":"588_CR12","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3390\/molecules22071135","volume":"22","author":"H Yuan","year":"2017","unstructured":"Yuan H, Ma Q, Cui H, Liu G, Zhao X, Li W, Piao G. How can synergism of traditional medicines beneft from network pharmacology? Molecules. 2017;22:1135.","journal-title":"Molecules"},{"key":"588_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3724\/SP.J.1009.2013.00110","volume":"11","author":"S Li","year":"2013","unstructured":"Li S, Zhang B. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med. 2013;11:110\u201320.","journal-title":"Chin J Nat Med"},{"key":"588_CR14","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1021\/acs.jnatprod.7b00433","volume":"80","author":"S Shin","year":"2017","unstructured":"Shin S, Lee S, Lee E, Kim K, Byun S. Caffeic acid phenethyl ester from the twigs of Cinnamomum cassia inhibits malignant cell transformation by inducing c-Fos degradation. J Nat Prod. 2017;80:2124\u201330.","journal-title":"J Nat Prod"},{"key":"588_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40199-018-0210-8","volume":"26","author":"S Sara","year":"2018","unstructured":"Sara S, Helia R, Athareh P, EIham J, Behjat K. Effect of Cinnamic acid and FOLFOX in diminishing side population and downregulating cancer stem cell markers in colon cancer cell line HT-29. Daru J Pharm Sci. 2018;26:19\u201329.","journal-title":"Daru J Pharm Sci"},{"key":"588_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-2946-6-13","volume":"6","author":"J Ru","year":"2014","unstructured":"Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang Y, Xu X, Li Y, Wang Y, Yang L. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13.","journal-title":"J Cheminform"},{"key":"588_CR17","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u2013504.","journal-title":"Genome Res"},{"key":"588_CR18","first-page":"1090","volume":"8","author":"B Pan","year":"2018","unstructured":"Pan B, Zang J, He J, Wang Z, Liu L. Add-On therapy with Chinese herb medicine Bo-Er-Ning capsule (BENC) improves outcomes of gastric cancer patients: a randomized clinical trial followed with bioinformatics-assisted mechanism study. Am J Cancer Res. 2018;8:1090\u2013105.","journal-title":"Am J Cancer Res"},{"key":"588_CR19","first-page":"6790","volume":"11","author":"B Pan","year":"2019","unstructured":"Pan B, Shi X, Ding T, Liu L. Unraveling the action mechanism of polygonum cuspidatum by a network pharmacology approach. Am J Transl Res. 2019;11:6790\u2013811.","journal-title":"Am J Transl Res"},{"key":"588_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12967-015-0398-z","volume":"13","author":"J Lu","year":"2015","unstructured":"Lu J, Li G, He K, Jiang W, Xu C, Li Z, Wang H, Wang W, Wang H, Teng X, Teng L. Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer. J Transl Med. 2015;13:42.","journal-title":"J Transl Med"},{"key":"588_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11655-019-3064-0","volume":"26","author":"T Luo","year":"2020","unstructured":"Luo T, Lu Y, Yan S, Xiao X, Rong X, Guo J. Network pharmacology in research of Chinese medicine formula: methodology, application and prospective. Chin J Integr Med. 2020;26:72\u201380.","journal-title":"Chin J Integr Med"},{"key":"588_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/ddr.21214","volume":"75","author":"C Da","year":"2014","unstructured":"Da C, Pei G. Network pharmacology: a rosetta stone for traditional Chinese medicine. Drug Dev Res. 2014;75:299\u2013312.","journal-title":"Drug Dev Res"},{"key":"588_CR23","first-page":"2094","volume":"13","author":"Y Pan","year":"2021","unstructured":"Pan Y, Chen Y, Wu C, Ai J, Wang Y, Jia J, Liu L. Network pharmacology-guided mechanism study uncovers inhibitory effect of Mahuang Decoction on lung cancer growth by impeding Akt\/ERK signaling pathways. Am J Transl Res. 2021;13:2094\u2013110.","journal-title":"Am J Transl Res"},{"key":"588_CR24","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1016\/j.csbj.2020.11.010","volume":"18","author":"B Pan","year":"2020","unstructured":"Pan B, Fang S, Zhang J, Pan Y, Liu H, Wang Y, Li M, Liu L. Chinese herbal compounds against SARS-CoV-2: puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor. Comput Struct Biotechnol J. 2020;18:3518\u201327.","journal-title":"Comput Struct Biotechnol J"},{"issue":"Pt A","key":"588_CR25","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jep.2014.10.017","volume":"158","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Xie R, Xiao Q, Li R, Shen X, Zhu X. Hedyotis diffusa Willd extract inhibits the growth of human glioblastoma cells by inducing mitochondrial apoptosis via AKT\/ERK pathways. J Ethnopharmacol. 2014;158(Pt A):404\u201311.","journal-title":"J Ethnopharmacol."},{"key":"588_CR26","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.ijbiomac.2020.10.272","volume":"166","author":"B Srinivas","year":"2021","unstructured":"Srinivas B, Shivamadhu M, Jayarama S. Musa acuminata lectin exerts anti-cancer effects on HeLa and EAC cells via activation of caspase and inhibitions of Akt, Erk, and Jnk pathway expression and suppresses the neoangiogenesis in in-vivo models. Int J Biol Macromol. 2021;166:1173\u201387.","journal-title":"Int J Biol Macromol"},{"key":"588_CR27","doi-asserted-by":"publisher","first-page":"6854","DOI":"10.3390\/ijms21186854","volume":"21","author":"A Kwak","year":"2020","unstructured":"Kwak A, Lee M, Yoon G, Cho S, Choi J, Chae J, Shim J. Deoxypodophyllotoxin, a lignan from Anthriscus sylvestris, induces apoptosis and cell cycle arrest by inhibiting the EGFR signaling pathways in esophageal squamous cell carcinoma cells. Int J Mol Sci. 2020;21:6854.","journal-title":"Int J Mol Sci"},{"key":"588_CR28","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.2147\/IJN.S174349","volume":"13","author":"X Zhao","year":"2018","unstructured":"Zhao X, Qi T, Kong C, Hao M, Wang Y, Li J, Liu B, Gao Y, Jiang J. Photothermal exposure of polydopamine-coated branched Au-Ag nanoparticles induces cell cycle arrest, apoptosis, and autophagy in human bladder cancer cells. Int J Nanomedicine. 2018;13:6413\u201328.","journal-title":"Int J Nanomedicine"},{"key":"588_CR29","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.bbrc.2011.06.144","volume":"411","author":"M Su","year":"2011","unstructured":"Su M, Chung H, Li Y. Deoxyelephantopin from Elephantopus scaber L. induces cell-cycle arrest and apoptosis in the human nasopharyngeal cancer CNE cells. Biochem Biophys Res Commun. 2011;411:342\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"588_CR30","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.3892\/or.2016.4695","volume":"35","author":"J Liu","year":"2016","unstructured":"Liu J, Li Q, Liu Z, Lin L, Zhang X, Cao M, Jiang J. Harmine induces cell cycle arrest and mitochondrial pathway-mediated cellular apoptosis in SW620 cells via inhibition of the Akt and ERK signaling pathways. Oncol Rep. 2016;35:3363\u201370.","journal-title":"Oncol Rep"},{"key":"588_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1756-9966-32-31","volume":"32","author":"E Niero","year":"2013","unstructured":"Niero E, Machado-Santelli G. Cinnamic acid induces apoptotic cell death and cytoskeleton disruption in human melanoma cells. J Exp Clin Cancer Res. 2013;32:31.","journal-title":"J Exp Clin Cancer Res"},{"key":"588_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186208","volume":"12","author":"P Anantharaju","year":"2017","unstructured":"Anantharaju P, Reddy D, Padukudru M, Kumari Chitturi C, Vimalambike M, Madhunapantula S. Induction of colon and cervical cancer cell death by cinnamic acid derivatives is mediated through the inhibition of Histone Deacetylases (HDAC). PLoS ONE. 2017;12: e0186208.","journal-title":"PLoS ONE"},{"key":"588_CR33","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.3390\/ijms18081809","volume":"18","author":"X Truong","year":"2017","unstructured":"Truong X, Park S, Lee Y, Jeong H, Moon J, Jeon T. Protocatechuic acid from pear inhibits melanogenesis in melanoma cells. Int J Mol Sci. 2017;18:1809.","journal-title":"Int J Mol Sci"},{"key":"588_CR34","doi-asserted-by":"publisher","first-page":"578","DOI":"10.4274\/tjps.galenos.2019.69335","volume":"17","author":"Z Motamedi","year":"2020","unstructured":"Motamedi Z, Amini SA, Raeisi E, Lemoigne Y, Heidarian E. Combined effects of protocatechuic acid and 5-fluorouracil on p53 gene expression and apoptosis in gastric adenocarcinoma cells. Turk J Pharm Sci. 2020;17:578\u201385.","journal-title":"Turk J Pharm Sci"},{"key":"588_CR35","first-page":"1131","volume":"31","author":"N Yunos","year":"2011","unstructured":"Yunos N, Beale P, Yu J, Huq F. Synergism from sequenced combinations of curcumin and epigallocatechin-3-gallate with cisplatin in the killing of human ovarian cancer cells. Anticancer Res. 2011;31:1131\u201340.","journal-title":"Anticancer Res"},{"key":"588_CR36","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.atherosclerosis.2004.05.020","volume":"176","author":"A Casaschi","year":"2004","unstructured":"Casaschi A, Rubio B, Maiyoh G, Theriault A. Inhibitory activity of diacylglycerol acyltransferase (DGAT) and microsomal triglyceride transfer protein (MTP) by the flavonoid, taxifolin, in HepG2 cells: potential role in the regulation of apolipoprotein B secretion. Atherosclerosis. 2004;176:247\u201353.","journal-title":"Atherosclerosis"},{"key":"588_CR37","first-page":"403","volume":"29","author":"Y Woo","year":"2012","unstructured":"Woo Y, Shin S, Hyun J, Lee S, Lee Y, Lim Y. Flavanones inhibit the clonogenicity of HCT116 cololectal cancer cells. Int J Mol Med. 2012;29:403\u20138.","journal-title":"Int J Mol Med"},{"key":"588_CR38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S1535-6108(03)00029-1","volume":"3","author":"J Isaacs","year":"2003","unstructured":"Isaacs J, Xu W, Neckers L. Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell. 2003;3:213\u20137.","journal-title":"Cancer Cell"},{"key":"588_CR39","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1517\/13543784.2014.902442","volume":"23","author":"K Jhaveri","year":"2014","unstructured":"Jhaveri K, Ochiana SO, Dunphy MP, Gerecitano JF, Corben AD, Peter RI, Janjigian YY, Gomes-DaGama EM, Koren J 3rd, Modi S, Chiosis G. Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions. Expert Opin Investig Drugs. 2014;23:611\u201328.","journal-title":"Expert Opin Investig Drugs"},{"key":"588_CR40","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41401-020-0398-2","volume":"42","author":"X Chen","year":"2021","unstructured":"Chen X, Liu P, Zhu W, Lou L. DCZ5248, a novel dual inhibitor of Hsp90 and autophagy, exerts antitumor activity against colon cancer. Acta Pharmacol Sin. 2021;42:132\u201341.","journal-title":"Acta Pharmacol Sin"},{"key":"588_CR41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.tranon.2019.11.007","volume":"13","author":"X Li","year":"2020","unstructured":"Li X, Lu J, Zhang L, Luo Y, Zhao Z, Li M. Clinical implications of monitoring ESR1 mutations by circulating tumor DNA in estrogen receptor positive metastatic breast cancer: a pilot study. Transl Oncol. 2020;13:321.","journal-title":"Transl Oncol"},{"key":"588_CR42","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1016\/j.ejca.2006.01.061","volume":"42","author":"K Nosho","year":"2006","unstructured":"Nosho K, Yamamoto H, Mikami M, Taniguchi H, Takahashi T, Adachi Y, Imamura A, Imai K, Shinomura Y. Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis. Eur J Cancer. 2006;42:2374\u201381.","journal-title":"Eur J Cancer"},{"key":"588_CR43","first-page":"87","volume":"63","author":"V Sulzyc-Bielicka","year":"2012","unstructured":"Sulzyc-Bielicka V, Domagala P, Hybiak J, Majewicz-Broda A, Safranow K, Domagala W. Colorectal cancers differ in respect of PARP-1 protein expression. Pol J Pathol. 2012;63:87\u201392.","journal-title":"Pol J Pathol"},{"key":"588_CR44","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1002\/ptr.6163","volume":"32","author":"Z Xie","year":"2018","unstructured":"Xie Z, Guo Z, Wang Y, Lei J, Yu J. Protocatechuic acid inhibits the growth of ovarian cancer cells by inducing apoptosis and autophagy. Phytother Res. 2018;32:2256\u201363.","journal-title":"Phytother Res"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-022-00588-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-022-00588-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-022-00588-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T16:16:22Z","timestamp":1650298582000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-022-00588-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,9]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["588"],"URL":"https:\/\/doi.org\/10.1186\/s13020-022-00588-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1086194\/v1","asserted-by":"object"}]},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,9]]},"assertion":[{"value":"16 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocols were approved by the Hospital Ethics Committee of Tianjin University ITCWM Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}